![]() |
Against Monopolydefending the right to innovate |
Monopoly corrupts. Absolute monopoly corrupts absolutely. |
||
Copyright Notice: We don't think much of copyright, so you can do what you want with the content on this blog. Of course we are hungry for publicity, so we would be pleased if you avoided plagiarism and gave us credit for what we have written. We encourage you not to impose copyright restrictions on your "derivative" works, but we won't try to stop you. For the legally or statist minded, you can consider yourself subject to a Creative Commons Attribution License. |
|
backWhen the government confers monopoly rights to drug companies The BBC reports about a drug that was available cheaply, got tweaked in a minor way and now available only in a much more expensive format. While the story is not about patenting, it is very similar to it as it is about licensing a drug, in this case for use in the UK, and excluding the old, yet still perfectly effective, drug from use. This is exactly what a patent does, and there are countless examples of pharmaceutical companies doing exactly these very marginal improvements to extract major rents from sick people. [Posted at 11/21/2010 02:14 PM by Christian Zimmermann on Pharmaceutical Patents Comments Forbes Article: Going Toe To Toe With Medical Device Giants. Very good article on the economic cost of defending yourself against a patent infringement lawsuit.
Forbes Table Below $10 million Cost to defend a high-stakes patent suit [Comment at 11/22/2010 07:19 PM by Steve R.] Have you closed the security breach yet? There were a lot of those inane comments posted overnight.
And why does the post above this one lack a comment submission form? It just says "Submit Comment" and then nothing. I thought maybe the page was cut off when I loaded it but I reloaded it several times and the rest of the page below the words "Submit Comment" was missing every single time. [Comment at 11/24/2010 12:13 PM by Wrenwrangler] The post about the drug does not accurately reflect the original article. The original article says that the unlicensed drug is still available, but the UK medical system requires using a licensed drug when it is available. So, the article is very little to do with patents and very much to do with an inflexible public health care system.
[Comment at 11/24/2010 03:00 PM by Anonymous] I must ask that people, collectively, not post more than a maximum of 9 comments to this site, total, between successive visits by me (generally several a day during the daylight hours on the west coast of North America; so a maximum of 9 during the west coast night and a maximum of 9 every four hours or so the rest of the time). (I post this now because I see someone has just made at least ten new comments in the course of a single hour.)
Otherwise it is impossible for me to use the Most Recent Comments sidebar to catch up on new comments since my previous visit and I am forced to page back through the last several days' worth of posts clicking every one that shows a non-zero number of comments and checking the date on the bottommost comment on each such post, which takes many minutes. Although with the generally poor comment quality and low activity at this blog lately I'm becoming sorely tempted to simply delete my bookmark for this site instead. [Comment at 11/26/2010 12:47 AM by Zachary Frederickson] I feel like I'm often looking for interesting things to read about a variety of subjects, but I manage to include your blog among my reads every day because you have interesting entries that I look forward to. Here's hoping there's a lot more great material coming!
Windows 7 Sale
[Comment at 12/07/2010 01:07 AM by Windows 7 Sale] In general, the main results from this theory compare price-fixing methods across market structures, analyse the impact of a certain structure on welfare, and play with different variations of technological/demand assumptions in order to assess its consequences on the abstract model of society. Most economic textbooks follow the practice of carefully explaining the perfect competition model, only because of its usefulness to understand "departures" from it (the so called imperfect competition models).
Mark Taylor,1z1-549 certified
[Comment at 12/08/2010 02:46 AM by mrktlr] Submit Comment |
|
![]() ![]() ![]() Most Recent Comments A Texas Tale of Intellectual Property Litigation (A Watering Hole Patent Trolls) Aunque suena insignificante, los números son alarmantes y nos demuestran que no es tan mínimo como at 06/29/2022 08:48 AM by Abogado de Accidente de Carro en Huntington Park
at 11/27/2021 05:53 PM by Nobody
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:57 PM by Anonymous
at 01/06/2021 06:47 PM by Anonymous
at 01/06/2021 06:47 PM by Anonymous
at 01/06/2021 06:42 PM by Anonymous
at 01/06/2021 06:42 PM by Anonymous
|